The Proposed Collaboration Sample Clauses

The Proposed Collaboration. The Parties have identified a collective desire to fund, monitor and oversee the functionality of the Tendring Mental Health Hub with NEECCG undertaking the lead in terms of providing a main point of contact and interface for partners and with the Hub, co-ordinating reporting and adherence to the Grant Agreement in place. The Parties recognise the need to focus on relationships and in creating an environment of trust, collaboration and innovation throughout the monitoring of the contract. The Parties agree to comply with the following principles of this MOU:
AutoNDA by SimpleDocs
The Proposed Collaboration. 2.1 The Parties have identified a collective desire to jointly fund the post of XXXXX team manager and apportion funding for the 2 administrators for the team. The split of funding is as follows: XXXXX Manager Post - divided equally between the 3 agencies XXXXX administrators x 2 – 40% OFPCC and 60% SBC The Budget for 2019-20 is £117,230 including on costs. This will be subject to incremental, annual inflationary increases
The Proposed Collaboration. 2.1 The Parties have identified a collective desire to jointly fund the post of XXXXX team manager and apportion funding for the 2 administrators for the team. The split of funding is as follows: − XXXXX Manager Post - divided equally between the 3 agencies. − MARAT administrators x 2 - 40% Police, Fire and Crime Commissioner for Essex and 60% Southend City Council. − The Budget for 2023-2024 is £192,950 including on costs. This will be subject to incremental, annual inflationary increases which will be reviewed annually.
The Proposed Collaboration a. The Parties have identified a collective desire to fund, monitor and oversee the functionality of the Tendring Mental Health Hub with the PFCC undertaking the lead in terms of providing a main point of contact and interface for partners and with the Hub, co-ordinating reporting and adherence to the Grant Agreement in place.

Related to The Proposed Collaboration

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Proposed Services A description of the Contractor’s proposed services to accomplish the specified work requirements, including dates of completion.

  • Independent Study Independent study is a program of independent study, research, and/or experience directly related to the duties described in the employee’s job description or related classification as determined by the Retraining and Study Committee, which promises professional values equivalent to that derived from formal study at a recognized educational institution.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Proposing Integration Activities in the Planning Submission No integration activity described in section 6.3 may be proposed in a CAPS unless the LHIN has consented, in writing, to its inclusion pursuant to the process set out in section 6.3(b).

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • ROAD WORK PHASE APPROVAL Purchaser shall obtain written approval from the Contract Administrator upon completion of each of the following phases of road work:  Drainage installation  Subgrade compaction  Rock compaction SUBSECTION RESTRICTIONS

  • Regulatory Approval 25.1 The Parties understand and agree that this Agreement and any amendment or modification hereto will be filed with the Commission for approval in accordance with Section 252 of the Act and may thereafter be filed with the FCC. The Parties believe in good faith and agree that the services to be provided under this Agreement are in the public interest. Each Party covenants and agrees to fully support approval of this Agreement by the Commission or the FCC under Section 252 of the Act without modification.

Time is Money Join Law Insider Premium to draft better contracts faster.